Skip to main content
. 2017 May 4;8(39):64853–64866. doi: 10.18632/oncotarget.17614

Figure 4. CB2 agonist adjuvant with AD-MSCs leads to myocardial activation of Stat3.

Figure 4

A. Representative photographs of immune blot of Akt, Erk, Stat3 and their phosphorylation. (n = 3), B.-D. Quantitative analysis of A.. *P < 0.05 between indicated groups.